Seeking Alpha

Shares of Lpath (LPTN.OB -31.8%) plummet after the biotech company temporarily suspends trials...

Shares of Lpath (LPTN.OB -31.8%) plummet after the biotech company temporarily suspends trials for its PEDigree and Nexus lipidomics-based antibody therapeutics. LPTN says it took the action when it learned its fill/finish contractor was not in FDA compliance for manufacturing requirements. (submitted by M.E. Garza)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|